World's Third-Largest OTC Player Sanofi's Consumer Health Unit Nears $16B Deal With Clayton Dubilier & Rice - Sanofi ( NASDAQ:SNY )
On Friday, Sanofi SA SNY said it is negotiating with Clayton Dubilier & Rice ( CD&R ) to potentially sell a 50% controlling stake in Opella, its consumer healthcare business.
| Ticker |
Sentiment |
Impact |
|
BX
|
Neutral
|
16 %
|
|
MS
|
Neutral
|
16 %
|
|
JNJ
|
Neutral
|
16 %
|
|
KVUE
|
Somewhat Bullish
|
16 %
|
|
TPG
|
Neutral
|
8 %
|
|
HLN
|
Neutral
|
16 %
|
|
GS
|
Neutral
|
16 %
|
|
GSK
|
Neutral
|
16 %
|
|
SNY
|
Somewhat Bullish
|
64 %
|
